John Cush/sgu.edu
Sep 23, 2026, 11:08
John Cush: Do JAK Inhibitors Increase VTE Risk After Joint Replacement?
John Cush, Editor and CEO RheumNow.com, shared a post on X:
“True or False: The TriNetX retrospective study found that JAK inhibitors significantly increased VTE risk in rheumatoid arthritis patients undergoing hip or knee replacement compared to TNF inhibitors.
Check your knowledge in the latest RheumIQ quiz.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 11:05Fonkou Steve: Blood Choice Requires Access to Safe Transfusion Options
-
Sep 23, 2026, 11:00Linda Rockwood: Cultural and Ethical Change in Transfusion Medicine
-
Sep 23, 2026, 10:30Michael Angers: Advancing Transfusion Safety Through Smarter Laboratory Workflows
-
Sep 23, 2026, 07:28Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health
-
Sep 23, 2026, 07:07Wolfgang Miesbach: Mechanisms of Liver Injury After Hemophilia A Gene Therapy
-
Sep 23, 2026, 06:24Nicolas Gendron: Everolimus and Venous Thromboembolic Risk in Kidney Transplantation
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management
-
Sep 23, 2026, 06:06Advancing Hemophilia Care and Patient Advocacy in Bangladesh – World Federation of Hemophilia
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH